10. Veuskens, J., Marie, D., Brown, S.C., Jacobs, M., and Negrutiu, I. (1995 The peptide-loading complex is a bottleneck in antigen presentation by major histocompatibility complex (MHC) class I molecules. While the structures of its individual components were known, the recent report of the 7.2 Å structure of the entire complex now fits them into their functional context, explaining this monumental step in antigen acquisition by MHC class I molecules.
Major histocompatibility complex (MHC) class I molecules present the immune system with peptide information reflecting the internal status of cells. If these peptides derive from 'non-self' entities, such as viral or mutated oncoproteins, T cells can selectively recognize and eliminate the affected cells. A key regulatory bottleneck in this process is the peptide-loading complex (PLC), located in the membrane of the endoplasmic reticulum (ER). Here, numerous components necessary for successful loading of peptides onto MHC class I molecules come together [1] . Although the individual components of this complex were identified nearly 20 years ago by Cresswell and others, their arrangement and communication within the greater PLC remained unknown [2] . A recent study from the group of Tamp e [3] now presents an EM structure of the entire PLC, substantiated by cross-linking studies dissecting how these various components interact to support peptide loading of MHC class I molecules. Here we discuss this beautiful structure in the historical context of our understanding of antigen presentation by MHC class I molecules.
We begin with a few key basics. MHC class I molecules are polymorphic and constitute the major transplantation antigens. In humans, they are products of three HLA loci -A, B and C -that further exhibit polymorphic alleles termed HLA-A1, HLA-A2, and so on, resulting in expression of different MHC class I variants on every nucleated cell. Other mammalian species possess the same MHC structure, but with different names. It took 20 years from identifying their existence before it was realized that these molecules present peptides from intracellular antigens to the immune system, in fact solving the riddle of how the 'external' immune system could monitor the 'internal' infection status of cells. In a series of experiments, starting with Townsend in 1986 [4] , the molecular pathway for MHC class I antigen presentation was painstakingly defined; first the molecules, then their respective structures. We now know that all cytosolic, nuclear, mitochondrial and ER proteins -including mutated oncoproteins and those derived from viruses -can be degraded by the 26S proteasome into small peptide fragments [5] and further trimmed to destruction by cytosolic peptidases, including leucine aminopeptidase (LAP), tripeptidyl peptidase II (TPPII), and many others ( Figure 1) . A small fraction of these peptides (likely less than 0.1%) escapes this fate by binding to the transporter associated with antigen processing (TAP), an ABC-family transporter for peptides located in the ER [6] . TAP not only translocates these peptides into the ER lumen, but also constitutes an integral part of the PLC complex, where it acts as a docking site for the MHC class I dedicated chaperone tapasin, and two general ER chaperones -the lectin calreticulin and the protein disulphide isomerase ERp57 (Figure 1 ). In fact, one TAP complex binds two MHC class I-tapasin-ERp57-calreticulin protein complexes [1] . Such assembly stoichiometry would suggest that peptides translocated by TAP can be sent straight into an MHC class I molecule in waiting at the PLC. This now appears unlikely based on the insights gleaned from the new structure of the PLC [3] .
As the bottleneck of MHC class I antigen presentation, the PLC is targeted by various viral proteins to inhibit their own presentation. One such protein, ICP47, is produced by the herpes virus and acts as a pseudopeptide with high affinity for the TAP peptide-binding site, thus occluding access to other peptides [7, 8] . Tamp e and colleagues used this information to generate an isolation tag of the full membrane-embedded PLC complex derived from a human Burkitt's lymphoma cell line. Analyses of the isolates by mass spectrometry confirmed retrieval of all expected PLC subunits, a tapasin splice variant and all HLA class I allelic variants, including the non-classical varieties. The protein complexes were analysed by cryo-EM, yielding a 9.9 Å map for the complete PLC complex and a 5.8 Å map of the MHC class I-chaperone sub-complex alone [3] . Into this map, crystal structures of individual PLC subunits could be docked successfully, providing unique insights into the molecular arrangement of the different subunits ( Figure 2 ). While the TAP subunits suffered from poor resolution and could not be placed within the PLC, its two associated tapasin-MHC class I-ERp57-calreticulin wings are revealed in a shape of a wigwam, or hut, containing two lateral openings for the release of translocated peptides from the PLC into the ER lumen (Figure 1) . Subsequently, the peptides need to re-enter the structure from the top in order to access the peptide-binding site of the MHC class I molecule.
Crystal structures of various polymorphic forms of MHC class I molecules have helped to elucidate the peptide-binding characteristics in atomic detail, defining the peptide-binding groove and revealing how different allelic variants of MHC class I anchor their preferred peptides in the binding pockets lined with polymorphic residues. This explains the evolutionary function of polymorphism, with different allelic variants presenting different fragments of Presentation of antigens by MHC class I molecules begins with degradation of cytosolic proteins into peptides by the 26S proteasome [13] . A small percentage of the resulting peptides escapes further processing by cytosolic proteases, such as TPP II [14] and LAP [15] , and is transported across the ER membrane by the TAP transporter [16] . Here, in the ER lumen, peptides can be loaded onto MHC class I molecules [17] residing in the PLC, which also contains the key chaperones tapasin, ERp57, and calreticulin [3] . Peptides that fail to successfully bind to MHC class I are further processed by ER luminal peptidases ERAP1 [18] and/or PDI [19] , or are transported back into the cytosol by the ERAD system [20] for complete degradation. Having acquired a suitable peptide, the MHC class I molecule exits the PLC by an unknown mechanism and traffics to the cell surface for presentation to the immune system. Structures of the indicated proteins are shown in surface representation. the same (for instance, viral) protein, thereby compensating for possible mutations through additive coverage by the other allelic variants expressed on the same cell [9] . Earlier crystal structures of MHC class I molecules also illustrated why presented peptides are typically 8 or 9 amino acids long: the ends of the peptide-binding groove are closed, disallowing larger sizes to fit, while shorter peptides lack sufficient anchors [10] . TAP, which serves various allelic variants of MHC class I, has in turn adapted to allow broad consideration of peptide sequences over 8 amino acids in length. When a peptide fails to find a fitting MHC molecule, it is either trimmed down further by protein disulphide isomerase (PDI) and ER aminopeptidase 1 (ERAP1), or rapidly transported back into the cytosol by the ER-associated degradation (ERAD) system for destruction.
It is obvious that an MHC class I molecule in association with the PLC (or located outside of the complex) needs to test many peptides until it encounters a suitable match. While all peptides initially bind to MHC class I molecules with similar on-rates, the latter undergo a conformational change to release the low-affinity clients and restart peptide selection until a 'high-affinity' or lower off-rate peptide is captured [11] . For this reason, the process of peptide selection is guided by chaperones that stabilize the open state of MHC class I and release them once they are loaded with a wellsuited peptide. How does this work? We can infer valuable lessons from the crystal structure of MHC class II in association with its dedicated chaperone HLA-DM [12] . Although MHC class I binds peptides in the ER, while MHC class II does so primarily in endosomes, structurally, MHC class II and HLA-DM are similar to MHC class I and tapasin. In the former complex, HLA-DM binds to the beginning of the peptide-binding groove of MHC class II, flipping a tryptophan to create an open state. Entry of a 'proper' peptide then flips the tryptophan back into position and traps the peptide. Even though the 5.8 Å cryo-EM structure of the PLC does not capture such details, it indeed reveals that tapasin interacts with an analogous position on the a 1-2 helix of an MHC class I molecule that is awaiting a peptide [3] . Such an arrangement could induce an interaction between residue R187 of tapasin and T134 of MHC class I, which is conserved among various allelic variants. The authors note additional interactions of the a 3 immunoglobulin-like domains of MHC class I and tapasin, in a situation once again similar to that observed for MHC class II and HLA-DM. MHC class I peptide loading is also facilitated by additional chaperones, and the PLC structure shows that both MHC class I-chaperone platforms on either side of the TAP transporter require tapasin binding. In doing so, they close the top of the wigwam through direct salt bridge interactions between the tapasin moieties at the core of the PLC. This arrangement is further stabilized by calreticulin, which binds both tapasin and the monoglucosylated glycan of MHC class I, as well as by ERp57, which makes contacts with calreticulin and tapasin. Of note, subparticle analyses also reveal the presence of complexes lacking (one or two) MHC class I and/or calreticulin molecules [3] . This illustrates the longstanding expectation that the TAP-tapasin-ERp57 complex truly comprises the core of the PLC, into which MHC class I-calreticulin enters for peptide loading.
The PLC facing the ER lumen thus resembles a wigwam without direct access of peptides to the MHC class I peptide-binding groove [3] . As a result, peptides released from TAP must leave the PLC for further trimming by ERAP1, or consideration by different allelic variants of MHC class I in association with other PLCs, or removal if no suitable match is found. The PLC structure by the Tamp e lab [3] not only completes the work of many labs over several decades, but also enables new questions to be explored. For instance, the PLC is one of the preferred complexes for inhibition by viral proteins, and structural analysis of the PLC under such conditions could reveal how this occurs. Furthermore, why MHC class I association with peptides occurs at the PLC even though peptides are not loaded in a direct manner can now be addressed. Since certain allelic variants of MHC class I prefer loading outside of the PLC, resulting in faster peptide acquisition and transport to the cell surface, could this imply that the PLC is more careful in, and thus takes longer to complete, the peptide selection process? With the first structure of the PLC finally in hand [3] , it marks the start of a new era in interrogating the details of the intricate assembly process of MHC class I -one of the master regulators of the immune system. Topographic maps are a basic organizational feature of nervous systems, and their construction involves both spatial and temporal cues. A recent study reports a novel mechanism of topographic map formation which relies on the timing of axon initiation.
Animal nervous systems are remarkably complex, requiring the generation of thousands of cell types and billions of synaptic connections. Sensory and motor systems frequently order these connections so spatial information of input or output is reflected within the brain and spinal cord, creating topographic maps. While progress has been made in understanding their formation, new maps and mechanisms are still being charted. In a study reported in a recent issue of Current Biology, Barsh et al. utilize the zebrafish to describe two parallel mechanisms of topographic map formation: a molecularly encoded strategy and a novel temporal strategy [1] .
Topographic maps mirror sensory information from the external world in the brain. The best-studied topographic map is that of the visual system. The projections of retinal ganglion cells, which carry light information to the thalamus, are ordered in the same way the cells are organized in the retina [2] . This topographic order is maintained at each level of the circuitry through to the visual processing center of the occipital cortex. Similar maps exist for olfactory ( Figure 1A) , auditory, and somatosensory information [2, 3] .
Motor systems are also organized topographically. In motor planning areas of the cortex, groups of neurons are organized in accordance to the corresponding body part each region controls [4] . A high degree of spatial order also exists within output neurons of motor systems. Motor neurons in the brain and spinal cord are positioned based on muscle target [5] . In the brain, oculomotor neurons are organized along the dorsoventral axis according to eye muscle target [6] , while spinal motor neurons are clustered in pools positioned relative to the location of limb muscles [7] .
Although topographic maps are abundant in both sensory and motor systems, we have not fully solved the mystery of how they are constructed. Elegant studies in the visual system revealed that chemical gradients exist to wire retinal ganglion axons to their
